相关实验视频

Updated: Jun 29, 2025

Intralymphatic Immunotherapy and Vaccination in Mice

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

在患有非霍奇金淋巴瘤的患者中进行疫苗接种的管理

Michele Merli¹, Andrea Costantini², Silvio Tafuri³

¹Division of Hematology, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico, Milan, Italy.

British journal of haematology

|March 27, 2024

概括

接种疫苗对于非霍奇金淋巴瘤患者至关重要,但抗CD20治疗会降低免疫反应. 本次审查审查了疫苗的疗效,并建议为这一脆弱人群改善免疫策略.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
预防传染病预防传染病

背景情况:

非霍奇金淋巴瘤 (NHL) 患者免疫力低下,增加了对感染的易感性.
随着COVID-19的流行,NHL患者急需有效的疫苗接种策略.
抗CD20单克隆抗体治疗显著损害了NHL患者的疫苗诱导的免疫反应.

研究的目的:

审查当前关于NHL患者COVID-19和其他疫苗疗效的数据.
为了确定在治疗后实现充分的疫苗反应的挑战.
提出基于证据的多学科建议,以优化NHL的疫苗管理.

主要方法:

对NHL患者疫苗疗效研究的综合文献综述.
对抗CD20治疗后接种疫苗后免疫反应的数据分析.
综合发现,制定临床建议.

主要成果:

在接受抗CD20治疗的NHL患者中,总是观察到疫苗疗效降低和免疫反应减弱.
该队列中COVID-19疫苗有效性的具体数据仍在出现,但表明潜在的局限性.
接种疫苗的时间和类型需要在治疗周期方面仔细考虑.

结论:

优化疫苗接种计划和策略对于免疫功能低下的NHL患者至关重要.
多学科的团队合作对于有效的疫苗管理在这个人群中至关重要.
需要进一步的研究,以建立在NHL患者中使用疫苗的最终指导方针,特别是关于新疗法.

关键词:

根据COVID-19的情况,其他非霍奇金淋巴瘤.这就是Rituximab.疫苗,疫苗的使用情况.佐斯特尔 (Zoster) 是一个指针.

更多相关视频

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

相关概念视频

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Vaccinations

Vaccinations